- Home
- NWTN vs ELUT Comparison
NWTN vs ELUT Comparison
Compare NWTN & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NWTN
- ELUT
- Stock Information
- Founded
- NWTN 2016
- ELUT 2015
- Country
- NWTN United Arab Emirates
- ELUT United States
- Employees
- NWTN N/A
- ELUT N/A
- Industry
- NWTN Auto Manufacturing
- ELUT Medical Specialities
- Sector
- NWTN Consumer Discretionary
- ELUT Health Care
- Exchange
- NWTN Nasdaq
- ELUT Nasdaq
- Market Cap
- NWTN 100.7M
- ELUT 94.0M
- IPO Year
- NWTN N/A
- ELUT 2020
- Fundamental
- Price
- NWTN $0.61
- ELUT $1.83
- Analyst Decision
- NWTN
- ELUT Strong Buy
- Analyst Count
- NWTN 0
- ELUT 2
- Target Price
- NWTN N/A
- ELUT $9.00
- AVG Volume (30 Days)
- NWTN 239.5K
- ELUT 40.2K
- Earning Date
- NWTN 01-01-0001
- ELUT 05-08-2025
- Dividend Yield
- NWTN N/A
- ELUT N/A
- EPS Growth
- NWTN N/A
- ELUT N/A
- EPS
- NWTN N/A
- ELUT N/A
- Revenue
- NWTN $37,333,000.00
- ELUT $24,375,000.00
- Revenue This Year
- NWTN N/A
- ELUT $39.35
- Revenue Next Year
- NWTN N/A
- ELUT $61.26
- P/E Ratio
- NWTN N/A
- ELUT N/A
- Revenue Growth
- NWTN N/A
- ELUT N/A
- 52 Week Low
- NWTN $0.30
- ELUT $1.79
- 52 Week High
- NWTN $5.00
- ELUT $5.24
- Technical
- Relative Strength Index (RSI)
- NWTN 75.98
- ELUT 39.97
- Support Level
- NWTN $0.38
- ELUT $1.79
- Resistance Level
- NWTN $0.42
- ELUT $2.07
- Average True Range (ATR)
- NWTN 0.08
- ELUT 0.20
- MACD
- NWTN 0.04
- ELUT -0.00
- Stochastic Oscillator
- NWTN 78.98
- ELUT 33.08
About NWTN NWTN Inc.
NWTN Inc is a pioneering smart electric vehicle company which aims to integrate avant-garde design, life-style personalization, IoT connectivity, and autonomous driving technology into a passenger-centric green premium mobility solution to the world.
About ELUT Elutia Inc.
Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.